Genix Pharmaceuticals Corp. Receives Approval for Drug Establishment License
Vancouver, British Columbia, July 15th, 2021 – Genix Pharmaceuticals Corporation (TSX-V:…
Genix Pharmaceuticals Corp. Lists on the OTCQB Venture Market Exchange
Vancouver, British Columbia, June 21st, 2021 – Genix Pharmaceuticals Corporation…
Genix Pharmaceuticals Corporation Provides a Corporate Update To Shareholders
VANCOUVER, June 07, 2021 – Genix Pharmaceuticals Corporation (TSXV: GENX)…
Genix Pharmaceuticals Corp. Announces AGM Results and Appoints Mahmoud Aziz to the Board and as President
Vancouver, British Columbia, May 20, 2021 — Genix Pharmaceuticals Corporation (TSX-V:…
Genix Pharmaceuticals Corporation Enters into Exclusive License and Supply Agreement for Canada’s First Generic Thyroid Medication
Vancouver, British Columbia, April 1, 2021 – Genix Pharmaceuticals Corporation…
Genix Pharmaceuticals Corporation prepares to file Abbreviated New Drug Submissions (ANDS) for its first ten Ophthalmic Drugs with Health Canada
Genix Introduces Paul Chow to the Board of Directors Vancouver,…